Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Chengdu Kanghua Biological Products Co Ltd
SZSE:300841
Price:
68.99
CNY
-0.68%
Market Closed
Market Cap:
¥9B
Income Statement
Earnings Waterfall
Chengdu Kanghua Biological Products Co Ltd
Chengdu Kanghua Biological Products Co Ltd
Income Statement
Chengdu Kanghua Biological Products Co Ltd
Chengdu Kanghua Biological Products Co Ltd
Currency: CNY
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
0
|
0
|
|
| Revenue |
825
N/A
|
1 039
+26%
|
1 119
+8%
|
1 136
+2%
|
993
-13%
|
1 292
+30%
|
1 322
+2%
|
1 400
+6%
|
1 567
+12%
|
1 447
-8%
|
1 458
+1%
|
1 421
-3%
|
1 382
-3%
|
1 577
+14%
|
1 611
+2%
|
1 684
+5%
|
1 648
-2%
|
1 432
-13%
|
1 258
-12%
|
1 175
-7%
|
1 212
+3%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(41)
|
(64)
|
(78)
|
(84)
|
(82)
|
(87)
|
(91)
|
(97)
|
(108)
|
(102)
|
(104)
|
(103)
|
(98)
|
(104)
|
(107)
|
(112)
|
(110)
|
(85)
|
(87)
|
(87)
|
(97)
|
|
| Gross Profit |
784
N/A
|
975
+24%
|
1 041
+7%
|
1 052
+1%
|
912
-13%
|
1 206
+32%
|
1 231
+2%
|
1 303
+6%
|
1 459
+12%
|
1 344
-8%
|
1 354
+1%
|
1 319
-3%
|
1 284
-3%
|
1 473
+15%
|
1 503
+2%
|
1 572
+5%
|
1 538
-2%
|
1 347
-12%
|
1 171
-13%
|
1 088
-7%
|
1 115
+3%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(384)
|
(504)
|
(535)
|
(519)
|
(449)
|
(585)
|
(584)
|
(620)
|
(706)
|
(727)
|
(773)
|
(781)
|
(799)
|
(873)
|
(836)
|
(882)
|
(865)
|
(828)
|
(804)
|
(797)
|
(847)
|
|
| Selling, General & Administrative |
(346)
|
(446)
|
(466)
|
(451)
|
(387)
|
(509)
|
(507)
|
(516)
|
(555)
|
(546)
|
(563)
|
(561)
|
(554)
|
(600)
|
(606)
|
(670)
|
(704)
|
(678)
|
(672)
|
(676)
|
(720)
|
|
| Research & Development |
(37)
|
(57)
|
(73)
|
(72)
|
(67)
|
(77)
|
(83)
|
(113)
|
(161)
|
(169)
|
(208)
|
(218)
|
(238)
|
(235)
|
(230)
|
(212)
|
(160)
|
(103)
|
(131)
|
(122)
|
(123)
|
|
| Depreciation & Amortization |
0
|
(6)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
(49)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
2
|
5
|
5
|
4
|
4
|
7
|
6
|
8
|
10
|
7
|
(2)
|
(3)
|
(6)
|
1
|
0
|
(0)
|
(1)
|
3
|
1
|
1
|
(4)
|
|
| Operating Income |
400
N/A
|
471
+18%
|
506
+7%
|
532
+5%
|
463
-13%
|
621
+34%
|
647
+4%
|
683
+6%
|
753
+10%
|
617
-18%
|
582
-6%
|
538
-8%
|
485
-10%
|
600
+24%
|
667
+11%
|
690
+3%
|
673
-2%
|
519
-23%
|
368
-29%
|
291
-21%
|
268
-8%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
7
|
14
|
21
|
35
|
266
|
295
|
306
|
295
|
63
|
68
|
65
|
64
|
58
|
(23)
|
(35)
|
(40)
|
(41)
|
(50)
|
(52)
|
(48)
|
(42)
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(2)
|
(2)
|
0
|
(2)
|
(0)
|
|
| Total Other Income |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
406
N/A
|
484
+19%
|
526
+9%
|
566
+8%
|
728
+29%
|
916
+26%
|
953
+4%
|
978
+3%
|
815
-17%
|
684
-16%
|
645
-6%
|
601
-7%
|
542
-10%
|
574
+6%
|
629
+10%
|
647
+3%
|
628
-3%
|
467
-26%
|
315
-33%
|
241
-23%
|
226
-6%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(63)
|
(76)
|
(82)
|
(88)
|
(81)
|
(86)
|
(88)
|
(85)
|
(85)
|
(86)
|
(77)
|
(71)
|
(58)
|
(65)
|
(76)
|
(80)
|
(82)
|
(68)
|
(45)
|
(35)
|
(44)
|
|
| Income from Continuing Operations |
344
|
408
|
444
|
478
|
648
|
829
|
864
|
893
|
729
|
598
|
568
|
531
|
484
|
509
|
553
|
568
|
546
|
399
|
270
|
207
|
182
|
|
| Net Income (Common) |
344
N/A
|
408
+19%
|
444
+9%
|
478
+8%
|
648
+36%
|
829
+28%
|
864
+4%
|
893
+3%
|
729
-18%
|
598
-18%
|
568
-5%
|
531
-7%
|
484
-9%
|
509
+5%
|
553
+9%
|
568
+3%
|
546
-4%
|
399
-27%
|
270
-32%
|
207
-23%
|
182
-12%
|
|
| EPS (Diluted) |
3.81
N/A
|
5.18
+36%
|
4.94
-5%
|
3.55
-28%
|
4.81
+35%
|
6.14
+28%
|
6.42
+5%
|
6.67
+4%
|
5.45
-18%
|
4.46
-18%
|
4.25
-5%
|
3.97
-7%
|
3.62
-9%
|
3.81
+5%
|
4.14
+9%
|
4.29
+4%
|
4.17
-3%
|
3.03
-27%
|
2.05
-32%
|
1.62
-21%
|
1.41
-13%
|
|
Switch to:
Switch to:
See Also
Discover More
